WP
ELDN icon

Woodline Partners’s Eledon Pharmaceuticals ELDN Stock Holding History

Woodline Partners’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-800,822
Closed -$2.07M – 1050
2025
Q3 		$2.07M Sell
800,822
-871,000
-52% -$2.55M 0.01% 728
2025
Q2 		$4.53M Hold
1,671,822
– – 0.02% 586
2025
Q1 		$5.67M Hold
1,671,822
– – 0.04% 476
2024
Q4 		$6.89M Buy
1,671,822
+828,930
+98% +$3.27M 0.05% 422
2024
Q3 		$2.1M Buy
842,892
+167,649
+25% +$449K 0.02% 473
2024
Q2 		$1.78M Buy
675,243
+23,304
+4% +$55.6K 0.02% 430
2024
Q1 		$1.34M Sell
651,939
-37,401
-5% -$66.7K 0.01% 447
2023
Q4 		$1.24M Buy
689,340
+85,347
+14% +$119K 0.01% 398
2023
Q3 		$827K Buy
603,993
+87,318
+17% +$117K 0.01% 462
2023
Q2 		$708K Hold
516,675
– – 0.01% 513
2023
Q1 		$1.22M Hold
516,675
– – 0.02% 460
2022
Q4 		$1.18M Hold
516,675
– – 0.02% 530
2022
Q3 		$1.43M Hold
516,675
– – 0.02% 505
2022
Q2 		$1.26M Sell
516,675
-156,463
-23% -$477K 0.02% 489
2022
Q1 		$2.65M Sell
673,138
-108,238
-14% -$420K 0.04% 340
2021
Q4 		$3.45M Hold
781,376
– – 0.05% 336
2021
Q3 		$4.83M Sell
781,376
-76,069
-9% -$532K 0.08% 258
2021
Q2 		$6.78M Sell
857,445
-33,610
-4% -$317K 0.13% 187
2021
Q1 		$9.53M Sell
891,055
-1,500
-0.2% -$22.6K 0.21% 123
2020
Q4 		$13.7M Buy
+892,555
New +$17M 0.36% 86

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Woodline Partners's ELDN Position: Q4 2025 in Review

Woodline Partners sold out of Eledon Pharmaceuticals (ELDN) in Q4 2025, closing a stake of 800,822 shares — an estimated $2.07M sold.

Woodline Partners first reported a position in ELDN in Q4 2020 and held it in 20 quarters. The position peaked at $13.7M in Q4 2020. 95 funds tracked by Wall St. Rank hold ELDN as of Q4 2025.

  • Woodline Partners reported no remaining Eledon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Woodline Partners sold 800,822 Eledon Pharmaceuticals shares in Q4 2025, an estimated $2.07M.
  • Woodline Partners first reported a position in Eledon Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Woodline Partners's Eledon Pharmaceuticals position peaked at $13.7M in Q4 2020.
  • 95 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.